Bullish option flow detected in Bristol Myers (BMY) Squibb with 19,990 calls trading, 2x expected, and implied vol increasing over 1 point to 26.58%. Mar-26 57.5 calls and Apr-26 62.5 calls are the most active options, with total volume in those strikes near 15,900 contracts. The Put/Call Ratio is 0.10. Earnings are expected on April 30th.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Barclays Names Eli Lilly (LLY) and Bristol-Myers Squibb (BMY) as Top Pharma Stocks to Buy Now
- Prothena expects to end year with $255M in cash, equivalents
- Tango Therapeutics weakness an ‘over reaction,’ says Stifel
- Bristol Myers: Biokin reports ‘positive’ results from Phase 3 study of iza-bren
- Bristol-Myers Squibb Advances Pediatric Lymphoma Combo, Signaling Quiet Upside for BMY Investors